Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Product/Service Approvals
![The World Needs New Antibiotics, but the Business Model Is Broken](http://www.nasdaqpicks.com/wp-content/uploads/2023/09/The-World-Needs-New-Antibiotics-but-the-Business-Model-Is-400x400.jpeg)
The World Needs New Antibiotics, but the Business Model Is Broken
- By nasdaqpicks.com
- . 26 September 2023
New drugs to defeat “superbug” bacteria aren’t reaching patients. Source link
![Teva Agrees to Pay $225 Million to Settle U.S. Price-Fixing Charges](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/Teva-Agrees-to-Pay-225-Million-to-Settle-US-Price-Fixing-400x400.jpeg)
Teva Agrees to Pay $225 Million to Settle U.S. Price-Fixing Charges
- By nasdaqpicks.com
- . 22 August 2023
The generic drugmaker’s U.S. unit also must sell the drug line for cholesterol treatment pravastatin. Source link
![Drug Shortages Are a Boon to One Industry: Compounding Pharmacies](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/Drug-Shortages-Are-a-Boon-to-One-Industry-Compounding-Pharmacies-400x400.jpeg)
Drug Shortages Are a Boon to One Industry: Compounding Pharmacies
- By nasdaqpicks.com
- . 7 August 2023
Hospitals increasingly rely on a sector that can start making drugs without FDA approval—and investment is pouring in. Source link
![Pfizer’s Covid Boost Crashes to Earth](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/Pfizers-Covid-Boost-Crashes-to-Earth-400x400.jpeg)
Pfizer’s Covid Boost Crashes to Earth
- By nasdaqpicks.com
- . 6 August 2023
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law.
![First Pill for Postpartum Depression Is Approved by FDA](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/First-Pill-for-Postpartum-Depression-Is-Approved-by-FDA-400x400.jpeg)
First Pill for Postpartum Depression Is Approved by FDA
- By nasdaqpicks.com
- . 5 August 2023
The pill, to be taken daily for at least two weeks, significantly reduced postpartum depression among new mothers in a recent trial. Source link
![FDA Approves First RSV Drug to Protect All Infants](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/FDA-Approves-First-RSV-Drug-to-Protect-All-Infants-400x400.jpeg)
FDA Approves First RSV Drug to Protect All Infants
- By nasdaqpicks.com
- . 17 July 2023
While the virus often leads to mild, coldlike symptoms, it is the leading cause of hospitalization of infants in the U.S. Source link
![FDA Approves First Over-the-Counter Birth-Control Pill](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/FDA-Approves-First-Over-the-Counter-Birth-Control-Pill-400x400.jpeg)
FDA Approves First Over-the-Counter Birth-Control Pill
- By nasdaqpicks.com
- . 13 July 2023
The Food and Drug Administration approved the first over-the-counter birth-control pill, significantly expanding access to contraception among women across the U.S. Source link
![FDA Approval Isn't Always a Happy Day for Biotech Investors](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/FDA-Approval-Isn039t-Always-a-Happy-Day-for-Biotech-Investors-400x400.jpeg)
FDA's OK Isn't Always a Happy Day for Biotech Investors
- By nasdaqpicks.com
- . 11 July 2023
In recent weeks, three closely watched FDA decisions came in positive for the companies—followed by their stocks going negative. Source link
![FDA Approval Isn't Always a Happy Day for Biotech Investors](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/FDA-Approval-Isn039t-Always-a-Happy-Day-for-Biotech-Investors-400x400.jpeg)
FDA Approval Isn't Always a Happy Day for Biotech Investors
- By nasdaqpicks.com
- . 11 July 2023
In recent weeks, three closely watched FDA decisions came in positive for the companies—followed by their stocks going negative. Source link
![FDA Approves Leqembi, Extending Alzheimer's Treatment to More Patients](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/FDA-Approves-Leqembi-Extending-Alzheimer039s-Treatment-to-More-Patients-400x400.jpeg)
FDA Approves Leqembi, Extending Alzheimer's Treatment to More Patients
- By nasdaqpicks.com
- . 7 July 2023
Medicare enrollees can get the anti-amyloid treatment as a result of the agency’s full approval. Source link